Bruker Stock Outperforms Other BCW Index Firms in Q1; Illumina Leads Decliners

Mar 28, 2007

This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.

Sparked by strong fourth-quarter results and a forecast of double-digit growth for 2007, shares of Bruker BioSciences rose 43 percent during the first quarter of 2007, outpacing the other 21 firms that comprise the BCW Index.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Twisting the Results

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Quickly, Quickly

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

'Right to Try' Heads Toward Law

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

This Week in Genome Research

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.

Main menu